Advertisement

You are subscribed to the Dermatology Times eNews.

MAUI DERM
Twitter Facebook

View Online  |  Download Magazine  |  Share With A Colleague  |  Print & Digital Subscribe  |  eNewsletter Subscribe

WELCOME TO MAUI DERM 2015

January 29, 2015

Thank you for reading the Dermatology Times Maui Derm 2015 conference e-newsletter.

Click to see all our coverage.

MORE HIGHLIGHTS

Pre-adolescent acne may be red flag

Dermatologists should keep an eye out for acne in pre-adolescent children as young as one year, because pimples may be a sign of serious medical problems. What lies beneath?

New drugs bring promising treatments for derm conditions

Promising new treatments for rosacea and leishmaniasis are among the highlights of a Maui Derm conference session about new drugs in dermatology. What you should know

RELATED ARTICLES

» Guidelines for managing childhood acne promote more consistent care

» Clues about rosacea pathogenesis spark treatment advances

» FDA approves Ivermectin 1% cream for rosacea

» Is HPV testing ready for 'prime' time in cervical cancer detection?

» Dupilumab promising in treatment of atopic dermatitis

Advertisement

Maui Derm @Maui_Derm

How are you managing your patients with psoriasis? http://mauiderm.com/?p=6840

Maui Derm @Maui_Derm

What's new regarding infectious disease? Dr Tyring provides us with clinical pearls... http://mauiderm.com/?p=6838

Maui Derm @Maui_Derm

What are the key issues we should remember when managing an itchy patient? Dr Zirwas provides his clinical pearls...mauiderm.com/?p=6849

Top Tweets

We welcome your feedback!
Please send your comments to:

Heather Onorati

Content Channel Director

Dermatology Times

[email protected]

DISCLAIMER:
This information has been independently developed and provided by the editors of Dermatology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

ModernMedicine logoUBM Advanstar logo